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Basic research by vascular surgeons: Why it is
important and how to keep it going
Peter K. Henke, MD,a Peter B. Brant-Zawadzki, MB BCh,b and Larry W. Kraiss, MD,b Ann Arbor, Mich;
and Salt Lake City, UtahTHE PROBLEM: BASIC RESEARCH ACTIVITY
BY VASCULAR SURGEONS IS DECLINING TO
DANGEROUSLY LOW LEVELS
Significant strides have been made in the treatment of
peripheral vascular disease, both medically and surgically.
Much of our understanding of atherosclerosis, aneurysms,
and peripheral vascular pathobiology comes from basic
bench research; vascular surgeons have made some of the
most important contributions, especially in the study of
abdominal aortic aneurysms and the problem of restenosis
after vascular intervention.
Certainly, technologic advances have been important
for improving vascular patient outcomes; however, the
long-range benefits of purely technologic advances are
modest. For example, although endovascular stent grafting
for abdominal aortic aneurysms has significantly improved
early morbidity and mortality, randomized trials suggest
that endovascular repairs have not measurably affected
long-term mortality.1,2 Hailed as a major advance, en-
dografts are subject to a different set of late complications,
require ongoing surveillance andmore frequent reinterven-
tions, and are arguably more expensive than traditional
open surgery.3 Enthusiasm for another technologic ad-
vance rooted in basic science—drug-eluting stents—has
recently been tempered because the antiproliferative action
of the drug coating may encourage late thrombosis.4 Du-
rable, long-term solutions to aneurysms and vascular occlu-
sive disease are more likely to arise from molecular-based
investigations of the biologic behavior of the vessel wall.
As a specialty, vascular surgery’s future is most depen-
dent on its broad-based professional commitment to the
treatment of vascular disease, not an overly narrow focus on
which type of specialist delivers a particular kind of treat-
ment. Arguably, our success during the past decade in
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882redefining ourselves as comprehensive vascular therapists,
not just open surgeons, is due to our long-standing interest
in researching, understanding, and treating a neglected
disease process rather than a primary technical focus. This
global interest in vascular disease often placed us first in line
at the bedside of the vascular patient, and a sustained
vibrant interest by our specialty in vascular research will
help keep us there.
There is, however, disturbing evidence that scholarly
activity in basic research by vascular surgeons is waning.
According to a previous analysis,5 basic science reports con-
stituted a relatively constant 18% to 20% of the papers
published by Society for Vascular Surgery (SVS) mem-
bers between 1985 and 1999 (approximately 260 papers
yearly). Using the same methodology, we reviewed the
scholarly output for the calendar year 2004 of the Distin-
guished Fellows, a group that comprises the membership of
the “old” SVS before the society merger that occurred in
2003. The overall number of citations retrieved was 1421,
derived from 645 Distinguished Fellows. The overall num-
ber of papers published yearly has been relatively constant
since 1984, at about two per year. However, the number of
basic science citations in 2004 attributed to SVS members
fell 30% since 1999 (197 vs. 260), comprising only 14% of
all manuscripts, compared with a historical fraction of 18%
to 20% focusing on basic science.
Even more dramatic, the proportion of SVS members
who were cited on a basic science paper fell from 36% to
42% between 1985 and 1999 to about 14% in 2004. Of
basic science articles, 49% of the publications were pub-
lished in a vascular or general surgical journal. Only 7% of
articles were published in a high-impact, broad, basic sci-
ence periodical such as an American Heart Association
journal or Journal of Clinical Investigation.Thus, although
the SVS membership continues to produce scholarly pub-
lications, the trend suggests fewer and fewer represent
basic, hypothesis-driven laboratory research.
Participation in the Surgical Forum at the American
College of Surgeons’ Annual Clinical Congress is another
barometer of vascular surgical research. Since 1999, the
number of basic investigational submissions has fallen from
92 to only 48 in 2006. Counted attendees in these sessions
have similarly fallen from 111 in 2003 to 68 in 2006. In
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of Vascular Surgery Forum Sessions from the traditional two
to one (K. Ozaki, personal communication, 10/2007).
Approximately 15 years ago, 50% of vascular fellow-
ships offered a basic science research year before, or some-
times after, clinical vascular training. A survey of recently
graduated fellows and program directors showed a majority
viewed this experience as positive, and vascular surgeons
practicing in an academic environment were more likely to
have had a research year during their fellowship. On the
other hand, the contribution of the fellow’s research expe-
rience in general surgery residency or medical school was
not significantly associated with a future academic posi-
tion.6 Although this was a retrospective study and suffers
from nonprospective validation, it stands to reason that the
contribution of the vascular fellowship committed research
year is (was) important for those desiring an academic
career.
A recent report of the successful Lifeline National In-
stitutes of Health (NIH) K-08 awardees revealed that these
surgeons had a median research experience of 2.0 years in
general surgery residency and 68% had a 1-year research
experience during their fellowship.7 Overall, academic vas-
cular surgeons who held an extramural research award had
spent 2.6 years devoted to research training during either
general or vascular surgical residency (L. W. Kraiss, unpub-
lished observations, 8/2007).
A more recent survey of all approved fellowships for
vascular surgery (information gathered by telephoning
each fellowship administrative assistant in the Accreditation
Council for GraduateMedical Education book of approved
residencies in 2004) revealed that only approximately 20%
of programs now offer dedicated research experience of9
months, despite many programs becoming accredited for
2-year total commitment (P. Henke, unpublished observa-
tions, 7/2005). The primary reason for the loss of the
research experience is the need to acquire endoluminal
skills and related competence.8,9 A modern vascular sur-
geon requires well-rounded training in vascular medicine,
endovascular, and open techniques, all of which require
increased training time. These newer clinical requirements
appear to have almost completely eliminated the traditional
research year in most training programs.
A specialty-wide change in academic focus was also
shown in a recent SVS-sponsored on-line survey from 2004
that evaluated the status of research within its membership
(www.vascularweb.org/). Of the respondents, 48% were in
an academic practice. Within this group of academic vascu-
lar surgeons, slightly 50% had performed basic science in
the last 15 years, and 81% spent20% of their overall time
involved with research activities. A minority of 18% re-
ported NIH funding, but more disconcerting was that 48%
had discontinued their basic science program during this
time frame. This contrasted with clinical research, where
only 16% had discontinued this activity. Overall, the con-
clusion that academic vascular surgeons are de-emphasizing
basic research in their professional careers is supported by
multiple lines of evidence and seems inescapable.THE POTENTIAL: VASCULAR SURGEONS CAN
STILL BE COMPETITIVE EXTRAMURALLY
FUNDED INVESTIGATORS
There is little doubt that vascular surgeons are capable
of performing quality basic research in vascular biology and
making significant contributions to the field. As a specialty,
vascular surgery has a long and distinguished commitment
to basic research. Historically, vascular surgeons and their
specialty society leaders have recognized the importance of
research. This commitment resulted in a landmark pro-
gram, the jointly sponsored von Liebig Lifeline Foundation
National Heart Lung & Blood Institute (NHLBI) Men-
tored Clinical Scientist Development Award (K-08). This
award mechanism identifies vascular surgeons with the
potential to become independent investigators (based on
NIH peer review) and provides them with additional sup-
plementary funding from the vascular societies. This repre-
sents a quality opportunity to develop as a vascular surgeon
investigator with mentoring from established scientists,
often from the basic biologic arena.
The mid-term results of this program have recently
been published, and the record of its participants reflect
better than average success in obtaining independent inves-
tigator status (NIH RO1 funding).7 Since its initiation, the
program has been expanded to include the American Vas-
cular Association–sponsored K23Mentored Clinical Inves-
tigator Award. Several other specialty surgical societies,
including the American College of Surgeons, have estab-
lished similar award mechanisms for young general sur-
geons.
Successful competition by a junior faculty surgeon for a
career development award, such as a K-08 or K-23, requires
the applicant to have preliminary data, solid laboratory
experience, and good writing skills. A new faculty member
just out of training and without research experience cannot
be expected to be competitive for this award. The question
then stands: “When are the basics of laboratory skills ac-
quired?”Historically, general surgery residency has allowed
a resident to spend 2 years in a basic science laboratory,
particularly in those institutions with a commitment to
produce academic surgeons. However, current surgical and
vascular surgical trainees seem unwilling to spend a decade
of their lives acquiring both clinical and investigative skills
that will allow them to flourish as vascular surgeon–scientists
and compete effectively for extramural funding. Many fac-
tors affect a trainee’s ultimate career choice, including
personal and financial obligations, family, and the institu-
tional environment.
Changes always bring opportunity in addition to angst.
One can complain about “lack of commitment” or “they
don’t make them the way they used to” when describing
current trainees in vascular surgery. Or, more construc-
tively, we can acknowledge the cultural differences between
current trainees and those of previous generations in the
way they regard the time commitment to prepare for an
academic career and then seek means to train vascular
surgeon–scientists in shorter periods of time. The extensive
JOURNAL OF VASCULAR SURGERY
April 2008884 Henke, Brant-Zawadzki, and Kraisstime commitment of training has started to be addressed by
the option of a Primary Certificate from the American
Board of Surgery and the integrated 05 vascular resi-
dency.
In our view, the main issue is not whether vascular
surgeons are capable of making quality basic science con-
tributions, it is whether our specialty continues to produce
and support surgeons who wish to make vascular biology
investigation a major part of their career.
THE SOLUTION: LEVERAGE NEW TRAINING
PARADIGMS TO IDENTIFY AND NURTURE
PROSPECTIVE VASCULAR SURGEON
SCIENTISTS
We believe that the traditional 9- to 10-year pathway to
an investigative career is obsolete. Although there may be
individual exceptions who should be aggressively sup-
ported, relying on this pipeline will lead to the eventual
extinction of the vascular surgeon–scientist. We are also
convinced that adequate (2 years) dedicated research
training is essential to have credibility in the scientific arena
and to be competitive for NIH funding.
We therefore advocate focusing on the new primary
certificate (05) programs as the principal source of the
next generation of vascular surgeon investigators. Adding 2
years of dedicated research training to this program in-
volves no more total training than the current traditional
pathway to a fully trained clinical vascular surgeon that
consists of 5 years of general surgery and 2 years of vascular
surgery. This strategy offers distinct advantages over the
traditional 9- to 10-year pathway:
● The overall duration of training is shorter, making an
investigative career more psychologically, culturally,
and financially feasible for many trainees.
● These programs offer flexibility in positioning the
research experience to the trainee’s optimal advant-
age.
In the old paradigm, the bulk of research training often
occurred during general surgery residency, typically sepa-
rating the formal research preparation from the first faculty
post by 3 to 4 years. The reality was that trainees with this
background were confronted with the need for a significant
“refresher” experience during the first years of their assis-
tant professorship. For many who were ultimately success-
ful in achieving research independence, this refresher was
essentially equivalent to a postdoctoral training period (the
previously mentioned basic science research year of the
vascular fellowship).
Although there are few reliable data regarding the
reasons for attrition among those who initially had research
aspirations, we suspect a major reason was the lack of an
opportunity to access or complete this refresher training.
The new training paradigms potentially allow the formal
research training to be positioned near the end of the
overall vascular surgical residency. It is exciting to think of
the possibilities for success when such trainees arrive at theirfirst faculty positions with a healthy amount of preliminary
data or even a completed grant application in hand. A
similar structured research plan for general surgeons was
put forth by Dr Linda Graham in her Society of University
Surgeons presidential address.10
The initial experience of the first three to four programs
to offer a 05 training option indicates that this is a very
attractive vehicle to graduating medical students with stel-
lar academic credentials. A disproportionately high number
of these trainees are likely to seriously consider research as a
career.
How should the vascular surgical community imple-
ment this strategy? We encourage all 05 programs to
seriously consider incorporating a structured research ex-
perience into their curriculum. Funding this nonclinical
experience will obviously be a challenge, but some mecha-
nisms exist such as the T32 NIH programs. This is also an
opportunity for the vascular societies to tangibly voice their
support for the vital role of investigation in the future of our
specialty. The American Vascular Association, the primary
educational foundation of the SVS, should develop grants
that will assist these programs in funding dedicated research
experiences for talented trainees who have made such an
early commitment to a vascular surgical career. During the
past decade, the SVS has invested significant time, effort,
and resources at the national level into ensuring that vascular
surgeons attained endovascular competence; we think a
similar effort is now necessary on behalf of the endangered
vascular surgeon–scientist.
The last unanswerable question is how many vascular
surgeon–scientists does society need? It is impossible to
place a number on this, but as shown here, scholarly activity
by vascular surgeons focusing on basic mechanisms of
disease is decreasing. Continued reliance on the traditional
research-training paradigm will lead to the loss of vascular
surgeon–scientists. The purpose of this essay is to make all
aware that silently and passively allowing this to happen
places our specialty in jeopardy as our intellectual link to the
disease processes affecting our patients becomes evermore
tenuous. Vascular surgery should exploit the opportunity
offered by its hard-won acquisition of a primary training
certificate and use it as the vehicle to train the next gener-
ation of vascular surgeon–scientists.
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